Illumina Awarded $26.7m In Patent Row

The verdict resolves an intellectual property dispute in which Illumina alleged Ariosa was violating Illumina's patents on prenatal genetic testing technology.

A San Francisco federal jury has awarded $26.7m to genetic testing company Illumina Inc. in a dispute related to patents for prenatal testing technology.

Illumina alleged that the previous and current versions of the Harmony noninvasive prenatal test from Ariosa Diagnostics Inc.violated multiple...

More from Diagnostics

More from Device Area